Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_assertion type Assertion NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_head.
- NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_assertion description "[Data suggest that nuclear FHL2 may serve as a novel biomarker predictive for prostate cancer with aggressive biology and point to a role of FHL2 in constitutive activation of AR-mediated growth signals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_provenance.
- NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_assertion evidence source_evidence_literature NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_provenance.
- NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_assertion SIO_000772 17145880 NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_provenance.
- NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_assertion wasDerivedFrom lhgdn-20090331 NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_provenance.
- NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_assertion wasGeneratedBy ECO_0000203 NP166994.RASMyDUWmfHZIN0-ttvQZ3gP9ZwnRy4e3-O7StgJ7OFr8130_provenance.